Quoin Pharmaceuticals (QNRX) Total Liabilities (2018 - 2026)

Quoin Pharmaceuticals has disclosed Total Liabilities across 9 years of filings, most recently posting $8.0 million for Q2 2026.

• In Q2 2026, Total Liabilities rose 26.34% year-over-year to $8.0 million; the TTM figure through Jun 2026 stood at $8.0 million (up 26.34% YoY), while the FY2025 annual figure was $7.3 million, up 11.78% from the prior year.
• Total Liabilities came in at $8.0 million for Q2 2026 at Quoin Pharmaceuticals, up from $6.9 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $8.0 million in Q2 2026 to a low of $729408.0 in Q1 2022.
• Average Total Liabilities over 5 years is $6.7 million, with a median of $7.0 million recorded in 2022.
• Year-over-year, Total Liabilities sank 55.27% in 2022 and soared 933.21% in 2023.
• Over 5 years, Total Liabilities stood at $7.1 million in 2022, then decreased by 7.74% to $6.5 million in 2023, then retreated by 0.01% to $6.5 million in 2024, then climbed by 11.78% to $7.3 million in 2025, then advanced by 10.54% to $8.0 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $8.0 million in Q2 2026, $6.9 million in Q1 2026, and $7.3 million in Q4 2025.